BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sethi NS, Kikuchi O, Duronio GN, Stachler MD, McFarland JM, Ferrer-Luna R, Zhang Y, Bao C, Bronson R, Patil D, Sanchez-Vega F, Liu JB, Sicinska E, Lazaro JB, Ligon KL, Beroukhim R, Bass AJ. Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model. Nat Genet 2020;52:219-30. [PMID: 32025000 DOI: 10.1038/s41588-019-0574-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Li K, Wang A, Liu H, Li B. Protocol for chemically induced murine gastric tumor model. STAR Protoc 2021;2:100814. [PMID: 34585155 DOI: 10.1016/j.xpro.2021.100814] [Reference Citation Analysis]
2 Kung C, Weber JD. It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy. Front Cell Dev Biol 2022;10:818744. [DOI: 10.3389/fcell.2022.818744] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Idowu S, Bertrand PP, Walduck AK. Homeostasis and Cancer Initiation: Organoids as Models to Study the Initiation of Gastric Cancer. Int J Mol Sci 2022;23:2790. [PMID: 35269931 DOI: 10.3390/ijms23052790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Link A, Bornschein J, Thon C. Helicobacter pylori induced gastric carcinogenesis - The best molecular model we have? Best Pract Res Clin Gastroenterol 2021;50-51:101743. [PMID: 33975683 DOI: 10.1016/j.bpg.2021.101743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hayakawa Y, Nakagawa H, Rustgi AK, Que J, Wang TC. Stem cells and origins of cancer in the upper gastrointestinal tract. Cell Stem Cell 2021;28:1343-61. [PMID: 34129814 DOI: 10.1016/j.stem.2021.05.012] [Reference Citation Analysis]
6 Martinho MS, Nancarrow DJ, Lawrence TS, Beer DG, Ray D. Chaperones and Ubiquitin Ligases Balance Mutant p53 Protein Stability in Esophageal and Other Digestive Cancers. Cell Mol Gastroenterol Hepatol 2021;11:449-64. [PMID: 33130332 DOI: 10.1016/j.jcmgh.2020.10.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wei W, Liu C, Yao R, Tan Q, Wang Q, Tian H. miR‑486‑5p suppresses gastric cancer cell growth and migration through downregulation of fibroblast growth factor 9. Mol Med Rep 2021;24:771. [PMID: 34490480 DOI: 10.3892/mmr.2021.12411] [Reference Citation Analysis]
8 Sahgal P, Huffman BM, Patil DT, Chatila WK, Yaeger R, Cleary JM, Sethi NS. Early TP53 Alterations Shape Gastric and Esophageal Cancer Development. Cancers (Basel) 2021;13:5915. [PMID: 34885025 DOI: 10.3390/cancers13235915] [Reference Citation Analysis]
9 Zeng Y, Jin RU. Molecular Pathogenesis, Targeted Therapies, and Future Perspectives for Gastric Cancer. Semin Cancer Biol 2021:S1044-579X(21)00297-2. [PMID: 34933124 DOI: 10.1016/j.semcancer.2021.12.004] [Reference Citation Analysis]
10 Ray K. New markers and models of premalignancy and the early development of gastric cancer. Nat Rev Gastroenterol Hepatol 2020;17:193-193. [DOI: 10.1038/s41575-020-0280-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Alzeeb G, Metges JP, Corcos L, Le Jossic-Corcos C. Three-Dimensional Culture Systems in Gastric Cancer Research. Cancers (Basel) 2020;12:E2800. [PMID: 33003476 DOI: 10.3390/cancers12102800] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
12 Paulson TG, Galipeau PC, Oman KM, Sanchez CA, Kuhner MK, Smith LP, Hadi K, Shah M, Arora K, Shelton J, Johnson M, Corvelo A, Maley CC, Yao X, Sanghvi R, Venturini E, Emde AK, Hubert B, Imielinski M, Robine N, Reid BJ, Li X. Somatic whole genome dynamics of precancer in Barrett's esophagus reveals features associated with disease progression. Nat Commun 2022;13:2300. [PMID: 35484108 DOI: 10.1038/s41467-022-29767-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yeoh KG, Tan P. Mapping the genomic diaspora of gastric cancer. Nat Rev Cancer 2021. [PMID: 34702982 DOI: 10.1038/s41568-021-00412-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Molinari C, Tedaldi G, Rebuzzi F, Morgagni P, Capelli L, Ravaioli S, Tumedei MM, Scarpi E, Tomezzoli A, Bernasconi R, Ambrosio MR, D'Ignazio A, Solaini L, Limarzi F, Ercolani G, Martinelli G, Ulivi P, Saragoni L. Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis. Gastric Cancer 2021;24:392-401. [PMID: 33156452 DOI: 10.1007/s10120-020-01135-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Ku CC, Wuputra K, Pan JB, Li CP, Liu CJ, Liu YC, Saito S, Chan TF, Lin CS, Wu DC, Yokoyama KK. Generation of Human Stomach Cancer iPSC-Derived Organoids Induced by Helicobacter pylori Infection and Their Application to Gastric Cancer Research. Cells 2022;11:184. [PMID: 35053302 DOI: 10.3390/cells11020184] [Reference Citation Analysis]
16 Yao K, Wei L, Zhang J, Wang C, Wang C, Qin C, Li S. Prognostic values of GPNMB identified by mining TCGA database and STAD microenvironment. Aging (Albany NY) 2020;12:16238-54. [PMID: 32833670 DOI: 10.18632/aging.103646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]